#药闻简讯# $Syndax制药(SNDX)$ A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101) $Kura Oncology(KURA)$
